已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Airy发布了新的文献求助10
刚刚
2秒前
2秒前
2秒前
ALONE完成签到,获得积分10
3秒前
daniu完成签到 ,获得积分10
5秒前
隐形曼青应助绿柚采纳,获得10
6秒前
田様应助Jiangzhibing采纳,获得10
7秒前
8秒前
星辰完成签到,获得积分10
8秒前
Owen应助灵巧尔云采纳,获得10
10秒前
10秒前
dly完成签到 ,获得积分10
11秒前
刘柑橘完成签到,获得积分10
13秒前
克劳修斯发布了新的文献求助10
15秒前
老迟到的羊完成签到 ,获得积分10
16秒前
斯文成协完成签到,获得积分10
16秒前
恰知发布了新的文献求助10
17秒前
生动路人发布了新的文献求助10
17秒前
18秒前
星辰大海应助小乔采纳,获得10
18秒前
温柔的伊完成签到 ,获得积分10
18秒前
20秒前
xcc完成签到,获得积分10
21秒前
wtt完成签到,获得积分10
22秒前
灵巧尔云发布了新的文献求助10
22秒前
令狐青亦发布了新的文献求助10
27秒前
鱼羊明完成签到 ,获得积分10
28秒前
冷静灵竹发布了新的文献求助10
28秒前
30秒前
32秒前
金戈完成签到,获得积分10
33秒前
33秒前
令狐青亦完成签到,获得积分20
35秒前
35秒前
Bo发布了新的文献求助10
36秒前
Catherine_Song完成签到 ,获得积分10
37秒前
skbz发布了新的文献求助10
37秒前
Leyii完成签到,获得积分10
38秒前
为非常的好应助浮浮世世采纳,获得10
40秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
Thomas Hobbes' Mechanical Conception of Nature 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5090007
求助须知:如何正确求助?哪些是违规求助? 4304665
关于积分的说明 13414601
捐赠科研通 4130315
什么是DOI,文献DOI怎么找? 2262199
邀请新用户注册赠送积分活动 1266136
关于科研通互助平台的介绍 1200822